This formulation comes in injection form is designed to provide a non-peptide, non-testosterone, and a more comprehensive wellness-based approach to support testosterone production in adult patients with secondary hypogonadism.

The clinical benefits of this formulation include:

• Support endogenous production of Testosterone via enzymatic pathway
• Reduce conversion of endogenous testosterone into estrogen molecules
• Help Leydig cell differentiation, resulting in more Leydig cell formation to produce testosterone
• Support neurocognitive function of the brain
• Improve metabolic profile, insulin sensitivity and increase IGF-1 levels
• Improve cardiovascular function

Recommended Dosing:
Inject 0.5ml SubQ twice weekly or 1.0ml IM once weekly

6ml vial for a 6 week supply